Intracellular (intracrine), non-PTH/PTHrP receptor mediated effects of PTHrP on prostate cancer cell growth.

被引：0
|
作者：
Burton, DW
Tu, S
Gujral, A
Patel, JA
Terkeltaub, RA
Rhim, JS
Deftos, LJ
机构：
[1] San Diego Vet Affairs Med Ctr, La Jolla, CA USA
[2] Univ Calif San Diego, La Jolla, CA 92093 USA
[3] NCI, NIH, Frederick, MD 21701 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1999年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
F403
引用
收藏
页码：S290 / S290
页数：1
相关论文
共 50 条
  • [41] Effects of bisphenol A and 17β-estradiol on vascular endothelial growth factor A and its receptor expression in the non-cancer and cancer ovarian cell lines
    Anna Ptak
    Ewa L. Gregoraszczuk
    Cell Biology and Toxicology, 2015, 31 : 187 - 197
  • [42] Rapid, non-destructive, cell-based screening assays for agents that modulate growth, death, and androgen receptor activation in prostate cancer cells
    Tavassoli, Peyman
    Snoek, Rob
    Ray, Mira
    Rao, Leticia Gomez
    Rennie, Paul S.
    PROSTATE, 2007, 67 (04): : 416 - 426
  • [43] Epidermal Growth Factor Receptor (EGFR)-Dependent Cell Growth Is Mediated By Fxr-Facilitated Akt And Erk1/2 Activation In Non-Small Cell Lung Cancer
    You, W.
    Jiang, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [44] Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition
    Fischer, Hendrik
    Taylor, Ninon
    Allerstorfer, Sigrid
    Grusch, Michael
    Sonvilla, Gudrun
    Holzmann, Klaus
    Setinek, Ulrike
    Elbling, Leonilla
    Cantonati, Heidelinde
    Grasi-Kraupp, Bettina
    Gauglhofer, Christine
    Marian, Brigitte
    Micksche, Michael
    Berger, Walter
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (10) : 3408 - 3419
  • [45] Antiestrogen Fulvestrant Enhances the Antiproliferative Effects of Epidermal Growth Factor Receptor Inhibitors in Human Non-Small-Cell Lung Cancer
    Garon, Edward B.
    Pietras, Richard J.
    Finn, Richard S.
    Kamranpour, Naeimeh
    Pitts, Sharon
    Marquez-Garban, Diana C.
    Desai, Amrita J.
    Dering, Judy
    Hosmer, Wylie
    von Euw, Erika M.
    Dubinett, Steven M.
    Slamon, Dennis J.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (03) : 270 - 278
  • [46] Acquired Resistance of Non-Small Cell Lung Cancer Cells to MET Kinase Inhibition Is Mediated by a Switch to Epidermal Growth Factor Receptor Dependency
    McDermott, Ultan
    Pusapati, Raju V.
    Christensen, James G.
    Gray, Nathanael S.
    Settleman, Jeff
    CANCER RESEARCH, 2010, 70 (04) : 1625 - 1634
  • [47] Activating Stress-Activated Protein Kinase-Mediated Cell Death and Inhibiting Epidermal Growth Factor Receptor Signaling: A Promising Therapeutic Strategy for Prostate Cancer
    Kumar, Raj
    Srinivasan, Sowmyalakshmi
    Pahari, Pallab
    Rohr, Juergen
    Damodaran, Chendil
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (09) : 2488 - 2496
  • [48] Clinically achievable dose of lovastatin in combination with sirna-mediated knockdown of androgen receptor induces strong growth-inhibitory effects on lncap prostate cancer cells
    Yanq, L.
    Desiniotis, A.
    Klocker, H.
    Bartsch, G.
    Eder, I. E.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 312 - 312
  • [49] Effects of gefitinib on serum epidermal growth factor receptor and HER2 in patients with advanced non-small cell lung cancer
    Gregorc, V
    Ceresoli, GL
    Floriani, I
    Spreafico, A
    Bencardino, KB
    Ludovini, V
    Pistola, L
    Mihaylova, Z
    Tofanetti, FR
    Ferraldeschi, M
    Torri, V
    Cappuzzo, F
    Crinò, L
    Tonato, M
    Villa, E
    CLINICAL CANCER RESEARCH, 2004, 10 (18) : 6006 - 6012
  • [50] THE EFFECTS OF EPIDERMAL GROWTH FACTOR (EGFR) RECEPTOR INHIBITORS ON THE IMMUNE SYSTEM IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Meniawy, Tarek
    Lake, Richard
    Nowak, Anna K.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S374 - S374
12345